Revive Therapeutics's market cap is currently C$4.19M. The company's EPS TTM is C$-0.014; its P/E ratio is ―; Revive Therapeutics is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 24	Jun 23	Jun 22	Jun 21	Jun 20
Income Statement
Total Revenue	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00	C$ 0.00
Gross Profit	C$ -328.00	C$ -434.00	C$ -578.00	C$ -775.00	C$ -28.27K
Operating Income	C$ -3.29M	C$ -5.41M	C$ -17.72M	C$ -18.50M	C$ -4.84M
EBITDA	C$ -5.60M	C$ -5.52M	C$ -17.74M	C$ -18.57M	C$ -5.26M
Net Income	C$ -5.62M	C$ -6.32M	C$ -17.83M	C$ -20.20M	C$ -4.27M
Balance Sheet
Cash & Short-Term Investments	C$ 823.07K	C$ 2.09M	C$ 3.92M	C$ 16.60M	C$ 1.48M
Total Assets	C$ 10.64M	C$ 14.25M	C$ 17.07M	C$ 29.81M	C$ 8.26M
Total Debt	C$ 25.22K	C$ 219.69K	C$ 327.73K	C$ 415.84K	C$ 465.85K
Net Debt	C$ -797.85K	C$ -1.87M	C$ -3.59M	C$ -16.18M	C$ -915.63K
Total Liabilities	C$ 3.40M	C$ 3.60M	C$ 4.46M	C$ 999.68K	C$ 831.55K
Stockholders' Equity	C$ 7.23M	C$ 10.65M	C$ 12.60M	C$ 28.81M	C$ 7.43M
Cash Flow
Free Cash Flow	C$ -3.29M	C$ -6.03M	C$ -13.06M	C$ -11.31M	C$ -2.52M
Operating Cash Flow	C$ -3.29M	C$ -6.03M	C$ -13.06M	C$ -8.31M	C$ -2.52M
Investing Cash Flow	C$ 0.00	C$ 0.00	C$ 0.00	C$ -2.72M	C$ 142.24K
Financing Cash Flow	C$ 1.98M	C$ 4.20M	C$ 376.35K	C$ 26.24M	C$ 3.28M

Currency in CAD

Revive Therapeutics Earnings and Revenue History

Income Statement >

Revive Therapeutics Debt to Assets

Balance Sheet >

Revive Therapeutics Cash Flow

Cash Flow >

Revive Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing